Change in Symptom and Quality of Life in COPD by Budesonide/Glycopyrronium/Formoterol Fumarate Pressurized Metered Dose Inhaler (BGF pMDI)

CompletedOBSERVATIONAL
Enrollment

106

Participants

Timeline

Start Date

May 16, 2022

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions
Pulmonary Disease, Chronic Obstructive
Trial Locations (17)

Unknown

Research Site, Nagoya

Research Site, Seto

Research Site, Tōon

Research Site, Kurume

Research Site, Tsuchiura

Research Site, Kanazawa

Research Site, Takamatsu

Research Site, Matsusaka

Research Site, Kashihara

Research Site, Chūō

Research Site, Fukui

Research Site, Fukuoka

Research Site, Hiroshima

Research Site, Kagoshima

Research Site, Miyazaki

Research Site, Osaka

Research Site, Ōita

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY